Global trends in systemic sclerosis-related mortality, 2001–2023: an epidemiological analysis using World Health Organization mortality data - Top-Institutions - MDSpire

Global trends in systemic sclerosis-related mortality, 2001–2023: an epidemiological analysis using World Health Organization mortality data

  • By

  • Belangoy, Keith Pardillada

  • Nishimura, Yoshito

  • Harada, Ko

  • Hagiya, Hideharu

  • Vu, Quynh Thi

  • Ouddoud, Hanane

  • Lescano, Judah Israel Ong

  • Yamamoto, Michio

  • Takeda, Tatsuaki

  • Hamano, Hirofumi

  • Koyama, Toshihiro

  • Zamami, Yoshito

  • March 6, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Autoimmune Diseases
    • Epidemiology

  • #2

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Rheumatology
    • Pulmonary Medicine
    • Autoimmune Diseases

  • #3

    University College London (UCL)
    University College London (UCL)

    London, N/A

    Key Differentiators

    • Rheumatology
    • Autoimmune Diseases
    • Epidemiology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Autoimmune Diseases
    • Clinical Research

  • #5

    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH
    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH

    Bethesda, MD

    Key Differentiators

    • Autoimmune Diseases
    • Rheumatology
    • Epidemiology

Original Source(s)

Global trends in systemic sclerosis-related mortality, 2001–2023: an epidemiological analysis using World Health Organization mortality data

  • by Belangoy, Keith Pardillada, Nishimura, Yoshito, Harada, Ko, Hagiya, Hideharu, Vu, Quynh Thi, Ouddoud, Hanane, Lescano, Judah Israel Ong, Yamamoto, Michio, Takeda, Tatsuaki, Hamano, Hirofumi, Koyama, Toshihiro, Zamami, Yoshito

  • March 6, 2026

Related Content

Neutrophil extracellular traps and pyroptosis: a molecular nexus linking systemic autoimmune diseases to atherosclerosis

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Comparative effectiveness and safety of biologics and targeted small-molecule therapies plus stable background therapy in systemic lupus erythematosus: a systematic review and network meta-analysis